domingo, 2 de mayo de 2021

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. - EClinicalMedicine

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. - EClinicalMedicine

No hay comentarios:

Publicar un comentario